Donepezil

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

ARICEPT, ARICEPT RDT – Pfizer Canada Inc. (NOC Search)

Patents:

1338808: EISAI, APOTEX, EISAI, MYLAN, MINT, EISAI, EISAI, GENPHARM, MYLAN, ACTAVIS, EISAI, RANBAXY, EISAI, RATIOPHARM, EISAI, PHARMASCIENCE, EISAI
2252806: EISAI, APOTEX, EISAI, ACTAVIS, EISAI, RANBAXY, EISAI, RATIOPHARM, EISAI, SANDOZ, EISAI, EISAI, GENPHARM, MYLAN, MINT, EISAI, EISAI, ACTAVIS, EISAI, ACCORD HEALTHCARE, AURO, EISAI, PHARMASCIENCE, EISAI

ACTAVIS, EISAI

PM(NOC) – T-120-12

APOTEX, EISAI

PM(NOC) – T-505-11

AURO, EISAI

PM(NOC) – T-1033-12

EISAI

PM(NOC) – T-414-12

EISAI, ACCORD HEALTHCARE

PM(NOC) – T-1032-12

EISAI, ACTAVIS

PM(NOC) – T-119-12

EISAI, APOTEX

PM(NOC) – T-967-11

EISAI, GENPHARM, MYLAN

PM(NOC) – T-1118-09 (2010 FC 684, 2011 FC 547)

EISAI, MYLAN

Appeal – A-226-11 (2012 FCA 103)

MINT, EISAI

PM(NOC) – T-12-12

PHARMASCIENCE, EISAI

PM(NOC) – T-907-11 – T-908-11

RANBAXY, EISAI

PM(NOC) – T-2184-10

RATIOPHARM, EISAI

PM(NOC) – T-713-10

SANDOZ, EISAI

PM(NOC) – T-103-10

Return to the Patented Medicine Litigation page.

Canadian Intellectual Property